Commerce Bank Has $35.98 Million Stake in CME Group Inc. (NASDAQ:CME)

Commerce Bank decreased its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 0.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 170,857 shares of the financial services provider’s stock after selling 1,618 shares during the quarter. Commerce Bank’s holdings in CME Group were worth $35,982,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of CME. Main Street Financial Solutions LLC bought a new stake in shares of CME Group during the third quarter worth $206,000. Larson Financial Group LLC raised its position in shares of CME Group by 293.6% during the third quarter. Larson Financial Group LLC now owns 551 shares of the financial services provider’s stock worth $110,000 after acquiring an additional 411 shares during the last quarter. MGO One Seven LLC raised its position in shares of CME Group by 19.0% during the third quarter. MGO One Seven LLC now owns 2,634 shares of the financial services provider’s stock worth $527,000 after acquiring an additional 421 shares during the last quarter. Signaturefd LLC raised its position in shares of CME Group by 11.7% during the third quarter. Signaturefd LLC now owns 5,002 shares of the financial services provider’s stock worth $1,002,000 after acquiring an additional 525 shares during the last quarter. Finally, Syon Capital LLC bought a new stake in shares of CME Group during the third quarter worth $366,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In other news, CEO Terrence A. Duffy sold 40,000 shares of the firm’s stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $210.91, for a total transaction of $8,436,400.00. Following the transaction, the chief executive officer now directly owns 67,455 shares of the company’s stock, valued at $14,226,934.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other CME Group news, Director Terry L. Savage sold 2,500 shares of CME Group stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $210.65, for a total transaction of $526,625.00. Following the sale, the director now directly owns 17,441 shares of the company’s stock, valued at approximately $3,673,946.65. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Terrence A. Duffy sold 40,000 shares of CME Group stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $210.91, for a total value of $8,436,400.00. Following the sale, the chief executive officer now directly owns 67,455 shares in the company, valued at $14,226,934.05. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,640 shares of company stock valued at $10,676,444. 0.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on CME shares. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $210.00 price objective (down from $235.00) on shares of CME Group in a research note on Friday, April 5th. Barclays boosted their target price on CME Group from $226.00 to $228.00 and gave the company an “equal weight” rating in a research note on Thursday, April 25th. Keefe, Bruyette & Woods boosted their target price on CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a research note on Thursday, April 25th. JPMorgan Chase & Co. boosted their target price on CME Group from $198.00 to $206.00 and gave the company a “neutral” rating in a research note on Thursday, April 25th. Finally, Morgan Stanley boosted their target price on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 9th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus target price of $217.80.

Get Our Latest Analysis on CME Group

CME Group Trading Up 1.0 %

NASDAQ:CME traded up $2.08 during trading hours on Friday, hitting $214.15. 497,301 shares of the company were exchanged, compared to its average volume of 1,749,748. The stock has a market capitalization of $77.11 billion, a price-to-earnings ratio of 24.13, a price-to-earnings-growth ratio of 5.59 and a beta of 0.48. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a one year low of $175.73 and a one year high of $223.80. The company has a fifty day simple moving average of $211.90 and a 200 day simple moving average of $211.33.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same period last year, the company posted $2.42 EPS. The business’s quarterly revenue was up 3.2% on a year-over-year basis. Sell-side analysts expect that CME Group Inc. will post 9.72 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th will be paid a dividend of $1.15 per share. The ex-dividend date of this dividend is Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.15%. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.